Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
SMAC mimetic; PXR agonist, IAP inhibitor.
α3β2, α3β4, α4β2 nAChR antagonist, indire...
BRD2/4/9 and CECR2 inhibitor.
Mycotoxin produced by Aspergillus; actin polyme...
Fatty acid metabolite of chlorophyll; RXR and P...
Trichothecene mycotoxin produced by Fusarium.
AMPK activator.
MEK1/2 inhibitor.
AurKB/C inhibitor.
Ethisterone derivative, synthetic steroid, used...
NSAID; COX-2 inhibitor.
PKC and PKD activator, carcinogen.
Sphingosine 1-phosphate antagonist.
Variety of flavonoid found in various plant sou...
GPR84 agonist.
NSAID; COX-1/2 inhibitor.
Nav1.8 Na+ channel blocker, potential Nav1.5 Na...
Coumarin; VKORC1 inhibitor.
MET inhibitor.
Sulforaphane homolog, ITC found in cruciferous ...